At the same time, he noted that "at the level of drugs for COVID-19, the situation may fundamentally change when monoclonal antibodies are obtained in the form of a drug against this virus."
Earlier, the general director of R-Pharm, the manufacturer of the Sputnik V vaccine, said that mass vaccination of Russians against coronavirus could begin at the end of November.
In turn, Russian leader Vladimir Putin, during a meeting with members of the board of the Russian Union of Industrialists and Entrepreneurs, said that it was necessary to roll out vaccination against coronavirus throughout Russia.